The China companion animal health market size is anticipated to reach USD 2.24 billion by 2028, according to the report. The market is expected to grow at a CAGR of 11.3% from 2021 to 2028. The key factors driving the market growth include rising initiatives by key market players, a growing pet population, and high usage of e-commerce channels.
The COVID-19 pandemic had a significant impact on the market in 2020. The adverse effects of the pandemic include supply chain bottlenecks, decreased sales & marketing initiatives, and dampened demand. However, pet ownership and expenditure continued to rise in the country during 2020. Even during the pandemic, online sales of the pet industry showed accelerated growth after an initial slump, as reported by China Daily. Key factors identified for this growth include increasing per capita GDP and pet humanization. For instance, according to the World Bank estimates, per capita GDP in China, in 2020, was USD 10,500, notably greater than the per capita GDP of USD 8,066 in 2015 and USD 4,550 in 2010.
The rising pet population in China is a key factor driving the market growth. The RADII Media reported that in 2020, the popularity of cats as pets was growing rapidly across China. The main reason identified for this trend was cats being relatively low-maintenance pets as compared to pet dogs. As per the Shanghai United Media Group, the preference for exotic and other companion animals is increasing among the young population in the country. Key factors fueling this growth include certain pets needing less upkeep as compared to dogs or horses. For example, geckos or small mammals require much less space, energy, and time from the pet owner as compared to mainstream pets.
Increasing usage of online channels for purchasing pet products is anticipated to propel the market in the coming years. China Daily reported that in 2019, online sales of the pet industry crossed 30 billion Yuan, or about USD 4.3 billion. 70% of the total sales were accounted for by e-commerce giants, such as Tmall and Taobao, as reported at Pet Fair Asia 2020. Key market players leveraged this opportunity to strengthen their market presence. In February 2019, Boehringer Ingelheim, for instance, launched the first-of-its-kind flagship store by a multinational animal health company on Tmall for pet parasiticides. The store was launched to provide customers with a reliable and convenient online purchasing channel for the company’s full range of pet parasiticides.
The rising pet population in China is a key factor driving the market growth. The RADII Media reported that in 2020, the popularity of cats as pets was growing rapidly across China. The main reason identified for this trend was cats being relatively low-maintenance pets as compared to pet dogs. As per the Shanghai United Media Group, the preference for exotic and other companion animals is increasing among the young population in the country. Key factors fueling this growth include certain pets needing less upkeep as compared to dogs or horses. For example, geckos or small mammals require much less space, energy, and time from the pet owner as compared to mainstream pets.
Increasing usage of online channels for purchasing pet products is anticipated to propel the market in the coming years. China Daily reported that in 2019, online sales of the pet industry crossed 30 billion Yuan, or about USD 4.3 billion. 70% of the total sales were accounted for by e-commerce giants, such as Tmall and Taobao, as reported at Pet Fair Asia 2020. Key market players leveraged this opportunity to strengthen their market presence. In February 2019, Boehringer Ingelheim, for instance, launched the first-of-its-kind flagship store by a multinational animal health company on Tmall for pet parasiticides. The store was launched to provide customers with a reliable and convenient online purchasing channel for the company’s full range of pet parasiticides.
China Companion Animal Health Market Report Highlights
- The companion animal medicine segment accounted for the highest share of the market in 2020 owing to the increased awareness about pet health and the high prevalence of diseases in pets
- Dogs represented the largest segment by animal type for both companion animal medicine as well as diagnostics markets in 2020
- By indication, non-infectious diseases dominated the China pet medicine as well as diagnostics markets in 2020
- The growth can be credited to the high awareness about animal health & diseases and increased pet expenditure & pet humanization
- Global trends, such as the One Health initiative, are expected to further propel awareness about animal health and boost the demand for medicines and diagnostics products for pets
- In June 2020, the World Bank Group approved a loan of USD 300 million to help strengthen select national and provincial systems in China to lower the risk of zoonoses and other emerging health threats as part of the Emerging Infectious Diseases Prevention, Preparedness and Response Project
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 Objectives
Chapter 2 Executive Summary
2.1 China Companion Animal Health Market Summary
Chapter 3 China Companion Animal Health Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2020
3.3 China Companion Animal Health Market Dynamics
3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.4 China Companion Animal Health Market Analysis Tools: Porter's
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 China Companion Animal Health Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6. Unmet Needs in Companion Animal Health Market
3.7. Pet Drug Development Analysis
3.8. Pipeline analysis
3.9. Access Path of Pet Medicine Market (U.S., Europe, APAC)
3.9.1. Regulatory Scenario for Drug Approval
3.9.2. Market Entry Strategies
3.9.2.1. Opportunity Analysis
3.9.2.2. Trends in the Pet Medicine Market
3.9.2.3. List of Major 5 Competitors Regulatory Landscape
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Disease Prevalence
4.2 Current and Future Impact Analysis
4.3 Impact of COVID-19 on Market Players
Chapter 5 China Companion Animal Health Market: Segment Analysis, By Type, 2016 - 2028 (USD Million)
5.1 Type Market Share Analysis, 2020 & 2028
5.2 China Companion Animal Health Market, by Type, 2016 to 2028
5.3 Companion Animal Medicine
5.3.1 Companion Animal Medicine market, 2016 - 2028 (USD Million)
5.4 Companion Animal Diagnostics
5.4.1 Companion Animal Diagnostics market, 2016 - 2028 (USD Million)
Chapter 6 China Companion Animal Medicine Market: Segment Analysis, By Animal Type, 2016 - 2028 (USD Million)
6.1 Animal Type Market Share Analysis, 2020 & 2028
6.2 China Companion Animal Medicine market, by Animal Type, 2016 to 2028
6.3 Dogs
6.3.1 Dogs market, 2016 - 2028 (USD Million)
6.4 Equine
6.4.1 Equine market, 2016 - 2028 (USD Million)
6.5 Cats
6.5.1 Cats market, 2016 - 2028 (USD Million)
6.6 Others
6.6.1 Others market, 2016 - 2028 (USD Million)
Chapter 7 China Companion Animal Medicine Market: Segment Analysis, By Indication, 2016 - 2028 (USD Million)
7.1 Indication Market Share Analysis, 2020 & 2028
7.2 China Companion Animal Medicine Market, by Indication, 2016 to 2028
7.3 Infectious Diseases
7.3.1 Infectious Diseases market, 2016 - 2028 (USD Million)
7.4 Non-Infectious Diseases
7.4.1 Non-Infectious Diseases market, 2016 - 2028 (USD Million)
7.5 General Ailments
7.5.1 General Ailments market, 2016 - 2028 (USD Million)
7.6 Others
7.6.1 Others market, 2016 - 2028 (USD Million)
Chapter 8 China Companion Animal Medicine Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
8.1 Product Market Share Analysis, 2020 & 2028
8.2 China Companion Animal Medicine Market, by Product, 2016 to 2028
8.3 Vaccines
8.3.1 Vaccines market, 2016 - 2028 (USD Million)
8.4 Pharmaceuticals
8.4.1 Pharmaceuticals market, 2016 - 2028 (USD Million)
8.5 Feed Additives
8.5.1 Feed Additives market, 2016 - 2028 (USD Million)
Chapter 9 China Companion Animal Diagnostics Market: Segment Analysis, By Animal Type, 2016 - 2028 (USD Million)
9.1 Animal Type Market Share Analysis, 2020 & 2028
9.2 China Companion Animal Diagnostics Market, by Animal Type, 2016 to 2028
9.3 Dogs
9.3.1 Dogs market, 2016 - 2028 (USD Million)
9.4 Equine
9.4.1 Equine market, 2016 - 2028 (USD Million)
9.5 Cats
9.5.1 Cats market, 2016 - 2028 (USD Million)
9.6 Others
9.6.1 Others market, 2016 - 2028 (USD Million)
Chapter 10 China Companion Animal Diagnostics Market: Segment Analysis, By Indication, 2016 - 2028 (USD Million)
10.1 Indication Market Share Analysis, 2020 & 2028
10.2 China Companion Animal Diagnostics Market, by Indication, 2016 to 2028
10.3 Infectious Diseases
10.3.1 Infectious Diseases market, 2016 - 2028 (USD Million)
10.4 Non-Infectious Diseases
10.4.1 Non-Infectious Diseases market, 2016 - 2028 (USD Million)
10.5 General Ailments
10.5.1 General Ailments market, 2016 - 2028 (USD Million)
10.6 Others
10.6.1 Others market, 2016 - 2028 (USD Million)
Chapter 11 China Companion Animal Diagnostics Market: Segment Analysis, By Diagnosis Method, 2016 - 2028 (USD Million)
11.1 Diagnosis Method Market Share Analysis, 2020 & 2028
11.2 China Companion Animal Diagnostics Market, by Diagnosis Method, 2016 to 2028
11.3 Analytical Services
11.3.1 Analytical Services market, 2016 - 2028 (USD Million)
11.4 Diagnostic Imaging
11.4.1 Diagnostic Imaging market, 2016 - 2028 (USD Million)
11.5 Bacteriology
11.5.1 Bacteriology market, 2016 - 2028 (USD Million)
11.6 Pathology
11.6.1 Pathology market, 2016 - 2028 (USD Million)
11.7 Molecular Diagnostics
11.7.1 Molecular Diagnostics market, 2016 - 2028 (USD Million)
11.8 Immunoassays
11.8.1 Immunoassays market, 2016 - 2028 (USD Million)
11.9 Parasitology
11.9.1 Parasitology market, 2016 - 2028 (USD Million)
11.10 Serology
11.10.1 Serology market, 2016 - 2028 (USD Million)
11.11 Virology
11.11.1 Virology market, 2016 - 2028 (USD Million)
Chapter 12 China Companion Animal Health Market - Competitive Analysis
12.1 Market Participant Categorization
12.1.1. Company Market Position Analysis
12.1.2. Synergy Analysis: Major Deals & Strategic Alliances
12.2. List of Major Players in China Pet Medicine Market
12.3 List of Major Players in China Pet Diagnostics Market
12.4 List of Key Small Molecule Drugs
12.5 List of Blockbuster Pet Drugs
Chapter 13 China Companion Animal Health Market - Company Profiles
13.1 Boehringer Ingelheim International GmbH
13.1.1 Company Overview
13.1.2 Financial performance
13.1.3 Product Benchmarking
13.1.4 Strategic Initiatives
13.2 Elanco
13.2.1 Company Overview
13.2.2 Financial performance
13.2.3 Product Benchmarking
13.2.4 Strategic Initiatives
13.3 Merck & Co., Inc.
13.3.1 Company Overview
13.3.2 Financial performance
13.3.3 Product Benchmarking
13.3.4 Strategic Initiatives
13.4 Zoetis
13.4.1 Company Overview
13.4.2 Financial performance
13.4.3 Product Benchmarking
13.4.4 Strategic Initiatives
13.5 Ceva
13.5.1 Company Overview
13.5.2 Financial performance
13.5.3 Product Benchmarking
13.5.4 Strategic Initiatives
13.6 Virbac
13.6.1 Company Overview
13.6.2 Financial performance
13.6.3 Product Benchmarking
13.6.4 Strategic Initiatives
13.7 Bimeda, Inc.
13.7.1 Company Overview
13.7.2 Financial performance
13.7.3 Product Benchmarking
13.7.4 Strategic Initiatives
13.8 IDEXX Laboratories
13.8.1 Company Overview
13.8.2 Financial performance
13.8.3 Product Benchmarking
13.8.4 Strategic Initiatives
13.9 Thermo Fisher Scientific
13.9.1 Company Overview
13.9.2 Financial performance
13.9.3 Product Benchmarking
13.9.4 Strategic Initiatives
13.10 Randox Laboratories
13.10.1 Company Overview
13.10.2 Financial performance
13.10.3 Product Benchmarking
13.10.4 Strategic InitiativesList of Tables
Table 1 List of secondary sources
Table 2 List of Major Players in China Pet Medicine Market
Table 3 List of Major Players in China Pet Diagnostics Market
Table 4 List of blockbuster pet drugs
Table 5 Elanco Patent-Off-Dates Analysis for Key Veterinary Pharmaceuticals
Table 6 Zoetis Patent-Off-Dates Analysis for Key Veterinary Pharmaceuticals
Table 7 List of Key Small Molecule Drugs for companion animals
Table 8 Product Pipeline Analysis
Table 9 Gross value of key patents, licenses, and Marketing authorizations (Virbac)
Table 10 Dechra Pharmaceuticals Product Pipeline Analysis
Table 11 Kindred Biosciences, Inc. Product Pipeline Snapshot
Table 12 List of five major competitors in the U.S.
Table 13 List of national competent authorities in the EEA for veterinary medicines
Table 14 List of five major competitors in Europe
Table 15 China Companion Animal Health market, by type, 2016 - 2028 (USD Million)
Table 16 China Companion Animal Medicine market, by animal type, 2016 - 2028 (USD Million)
Table 17 China Companion Animal Medicine market, by indication, 2016 - 2028 (USD Million)
Table 18 China Companion Animal Medicine market, by product, 2016 - 2028 (USD Million)
Table 19 China Companion Animal Diagnostics market, by animal type, 2016 - 2028 (USD Million)
Table 20 China Companion Animal Diagnostics market, by indication, 2016 - 2028 (USD Million)
Table 21 China Companion Animal Diagnostics market, by diagnosis method, 2016 - 2028 (USD Million)List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value - chain - based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 China Companion Animal Medicine Market Snapshot (USD Million)
Fig. 10 China Companion Animal Diagnostics Market Snapshot (USD Million)
Fig. 11 China Companion Animal Medicine market: Animal Type movement analysis
Fig. 12 China Companion Animal Medicine Market: Animal Type Dashboard
Fig. 13 Dogs Medicine market, 2016 - 2028 (USD Million)
Fig. 14 Equine Medicine market, 2016 - 2028 (USD Million)
Fig. 15 Estimated pet cat population in China, 2017 to 2020
Fig. 16 Cats Medicine market, 2016 - 2028 (USD Million)
Fig. 17 Others Medicine market, 2016 - 2028 (USD Million)
Fig. 18 China Companion Animal Medicine market: Indication movement analysis
Fig. 19 China Companion Animal Medicine Market: Indication Dashboard
Fig. 20 Infectious Disease Medicine market, 2016 - 2028 (USD Million)
Fig. 21 Non - Infectious Disease Medicine market, 2016 - 2028 (USD Million)
Fig. 22 General Ailments Medicine market, 2016 - 2028 (USD Million)
Fig. 23 Other Indications Medicine market, 2016 - 2028 (USD Million)
Fig. 24 China Companion Animal Diagnostics market: Animal Type movement analysis
Fig. 25 China Companion Animal Diagnostics Market: Animal Type Dashboard
Fig. 26 Estimated pet dog population in China, 2017 to 2020
Fig. 27 Dogs Diagnostics market, 2016 - 2028 (USD Million)
Fig. 28 Estimated horse population in China, 2017 to 2020
Fig. 29 Equine Diagnostics market, 2016 - 2028 (USD Million)
Fig. 30 Cats Diagnostics market, 2016 - 2028 (USD Million)
Fig. 31 Others Diagnostics market, 2016 - 2028 (USD Million)
Fig. 32 China Companion Animal Diagnostics market: Indication movement analysis
Fig. 33 China Companion Animal Diagnostics Market: Indication Dashboard
Fig. 34 Infectious Diseases Diagnostics Market, 2016 - 2028 (USD Million)
Fig. 35 Non - Infectious Diseases Diagnostics Market, 2016 - 2028 (USD Million)
Fig. 36 General Ailments Diagnostics market, 2016 - 2028 (USD Million)
Fig. 37 Others diseases Diagnostics market, 2016 - 2028 (USD Million)
Fig. 38 China Companion Animal Diagnostics market: Diagnosis Method movement analysis
Fig. 39 China Companion Animal Diagnostics Market: Diagnosis Method Dashboard
Fig. 40 Analytical Services market, 2016 - 2028 (USD Million)
Fig. 41 Diagnostic Imaging market, 2016 - 2028 (USD Million)
Fig. 42 Bacteriology market, 2016 - 2028 (USD Million)
Fig. 43 Pathology market, 2016 - 2028 (USD Million)
Fig. 44 Molecular Diagnostics market, 2016 - 2028 (USD Million)
Fig. 45 Immunoassays market, 2016 - 2028 (USD Million)
Fig. 46 Parasitology market, 2016 - 2028 (USD Million)
Fig. 47 Serology market, 2016 - 2028 (USD Million)
Fig. 48 Virology market, 2016 - 2028 (USD Million)
Fig. 49 Main phases of veterinary drug development
Fig. 50 China Companion Animal Health Market Snapshot (USD Million)
Fig. 51 China Companion Animal Health market: Type movement analysis
Fig. 52 China Companion Animal Health Market: Type Dashboard
Fig. 53 China Companion Animal Medicine market, 2016 - 2028 (USD Million)
Fig. 54 China Companion Animal Diagnostics market, 2016 - 2028 (USD Million)
Fig. 55 Market participant categorization
Fig. 56 Company market position analysis: Heat map analysis
Fig. 57 China Companion Animal Medicine market: Product movement analysis
Fig. 58 China Companion Animal Medicine Market: Product Dashboard
Fig. 59 Vaccines market, 2016 - 2028 (USD Million)
Fig. 60 Pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 61 Feed additives market, 2016 - 2028 (USD Million)
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Elanco
- Merck & Co. Inc.
- Zoetis
- Ceva
- Virbac
- Bimeda, Inc.
- IDEXX Laboratories
- Thermo Fisher Scientific
- Randox Laboratories
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 105 |
| Published | December 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 1.06 Billion |
| Forecasted Market Value ( USD | $ 2.24 Billion |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | China |
| No. of Companies Mentioned | 10 |
